$DORM

Dorman Products, Inc.

No enriched coverage for $DORM in the last 7 days.

$99K
Long Donna M.
100%
See all $DORM insider activity →
Med

Dorman Products (DORM) Q2 2026 Earnings Call Transcript

Dorman Products (DORM) reported Q2 2026 net sales of $544.6 million (+0.7%) and adjusted diluted EPS of $3.08 (+50%), helped by a $1.18 per share IEEPA tariff refund. Adjusted gross margin rose to 46.1%. FY2026 guidance: net sales growth 3% to 5% and adjusted EPS $8.50 to $8.80.

Bowen Gregory C. sold $512K of DORM

Bowen Gregory C. (VP, Chief Accounting Officer) sold 3,531 shares of Dorman Products, Inc. (DORM) at an average of $145.01 ($144.72–$145.23, $0.51M total) across 2 trades on 2026-08-05.

Dorman Products Q2 net sales rise to $544.6 million

Dorman Products reported Q2 2026 net sales of $544.6 million, up 0.7% from $541.0 million. Net income rose to $87.8 million and diluted EPS increased 53% to $2.93, aided by IEEPA tariff cost recovery, according to the company. Operating cash flow was $152.6 million; it repurchased $47 million of shares. Updated guidance: net sales growth 3% to 5% and EPS $7.93 to $8.23.

DORM sentiment & insider activity

Recent DORM coverage spans financial news, earnings and insider activity.

In the last 30 days, DORM insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($99K). The most active reporter was Long Donna M., SVP, CIO, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving DORM

  • Guidance mix improves headline EPS via one-time IEEPA refund, while top-line guidance is lowered due to pricing and first-half performance.

    fool.com · Aug 11, 2026

  • This is a routine insider sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.

    SEC EDGAR · Aug 7, 2026

  • The quarter shows earnings leverage and cash generation, with updated full-year guidance providing a near-term valuation and positioning anchor.

    quiverquant.com · Aug 3, 2026

  • Q2 results showed strong EPS and cash flow, while guidance was updated lower on net sales growth versus prior guidance, with tariff recovery cited as a key driver.

    SEC EDGAR 8-K · Aug 3, 2026

  • Credit agreement amendment changes lender composition and revolver/LC participation, which can affect near-term funding terms and perceived leverage risk.

    SEC EDGAR 8-K · Jun 17, 2026

alphai scores every news story that mentions DORM with an AI model for sentiment and relevance, and aggregates insider trades from Dorman Products, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $DORM

Score
$DORMMedAI 8/10

Dorman Products (DORM) Q2 2026 Earnings Call Transcript

Dorman Products (DORM) reported Q2 2026 net sales of $544.6 million (+0.7%) and adjusted diluted EPS of $3.08 (+50%), helped by a $1.18 per share IEEPA tariff refund. Adjusted gross margin rose to 46.1%. FY2026 guidance: net sales growth 3% to 5% and adjusted EPS $8.50 to $8.80.

$DORMMedAI 8/10

Dorman Products Q2 net sales rise to $544.6 million

Dorman Products reported Q2 2026 net sales of $544.6 million, up 0.7% from $541.0 million. Net income rose to $87.8 million and diluted EPS increased 53% to $2.93, aided by IEEPA tariff cost recovery, according to the company. Operating cash flow was $152.6 million; it repurchased $47 million of shares. Updated guidance: net sales growth 3% to 5% and EPS $7.93 to $8.23.

Dorman Products, Inc. (DORM): Results of Operations and Financial Condition

Dorman Products, Inc. (DORM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Dorman Products, Inc. Reports Second Quarter 2026 Results; Updates 2026 Guidance Highlights (All comparisons are to the prior year period unless otherwise noted) : • Net sales of $544.6 million for the quarter, up 0.7% • Diluted earnings per share (“EPS”) of $2.93, u

$DORMLow

Dorman Products, Inc. (DORM): Entry into a Material Definitive Agreement

Dorman Products, Inc. (DORM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 d64281dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 Execution Version AMENDMENT NO. 3 , dated as of June 16, 2026 (this “ Amendment No. 3 ”), to the Credit Agreement, dated as of August 10, 2021 (as amended by Amendment No. 1, dated as of October 4, 2022, as further amended b

$DORMLow

Insider Selling: Dorman Products (NASDAQ:DORM) Insider Sells 2,000 Shares of Stock

Dorman Products (NASDAQ:DORM) insider John Mcknight recently sold 2,000 shares of the company's stock for $257,600, reducing his ownership by 18%. This transaction occurred after the company reported strong Q3 earnings, beating EPS expectations, and provided positive FY2025 guidance. Analysts currently rate Dorman Products as a "Buy" with a consensus target price of $180.50.

Related tickers